tiprankstipranks
Advertisement
Advertisement

AU:NOX Stock Latest News

Noxopharm moves SOF-SKN toward U.S. FDA pathway to boost autoimmune portfolio
Company AnnouncementsNoxopharm moves SOF-SKN toward U.S. FDA pathway to boost autoimmune portfolio
4d ago
NOX
Noxopharm Sofra Platform Backed in $1m Grant for Childbirth Injury Treatment
PremiumCompany Announcements
Noxopharm Sofra Platform Backed in $1m Grant for Childbirth Injury Treatment
9d ago
NOX
Noxopharm unveils human-like TLR8 model to accelerate cancer immunotherapy program
PremiumCompany Announcements
Noxopharm unveils human-like TLR8 model to accelerate cancer immunotherapy program
10d ago
NOX
Noxopharm Starts SOF-SKN Manufacturing Ahead of Cutaneous Lupus Trial
PremiumCompany Announcements
Noxopharm Starts SOF-SKN Manufacturing Ahead of Cutaneous Lupus Trial
1M ago
NOX
Noxopharm Director Restructures Holding Via Off-Market Share Transfer
PremiumCompany Announcements
Noxopharm Director Restructures Holding Via Off-Market Share Transfer
1M ago
NOX
Noxopharm Showcases Potent New TLR8-Based Immuno-Oncology Platform
PremiumCompany AnnouncementsNoxopharm Showcases Potent New TLR8-Based Immuno-Oncology Platform
2M ago
NOX
Noxopharm Plans CEO Option Grant Tied to Long-Term Share Price Growth
Premium
Company Announcements
Noxopharm Plans CEO Option Grant Tied to Long-Term Share Price Growth
2M ago
NOX
Noxopharm Taps Novotech to Advance SOF-SKN Toward Key FDA Milestone
Premium
Company Announcements
Noxopharm Taps Novotech to Advance SOF-SKN Toward Key FDA Milestone
2M ago
NOX
Noxopharm Data Backs SOF-16’s Anti-Inflammatory Potential in Autoimmune Disease
PremiumCompany Announcements
Noxopharm Data Backs SOF-16’s Anti-Inflammatory Potential in Autoimmune Disease
2M ago
NOX
Noxopharm Names CFO Shawn van Boheemen as New Company Secretary
PremiumCompany Announcements
Noxopharm Names CFO Shawn van Boheemen as New Company Secretary
2M ago
NOX
Noxopharm deepens Sofra push with Tezcat deal, CEO shift and key trial progress
PremiumCompany Announcements
Noxopharm deepens Sofra push with Tezcat deal, CEO shift and key trial progress
3M ago
NOX
Noxopharm’s SOF-SKN shows prolonged skin retention in preclinical study
PremiumCompany Announcements
Noxopharm’s SOF-SKN shows prolonged skin retention in preclinical study
3M ago
NOX
Noxopharm Tightens Disclosure Controls After CEO Resigns and Director Notices Updated
PremiumCompany AnnouncementsNoxopharm Tightens Disclosure Controls After CEO Resigns and Director Notices Updated
3M ago
NOX
Noxopharm CEO Resigns as Biotech Awaits Successor Amid Strategic Shift
Premium
Company Announcements
Noxopharm CEO Resigns as Biotech Awaits Successor Amid Strategic Shift
3M ago
NOX
Noxopharm Half-Year Loss Widens as Net Tangible Assets Turn Negative
Premium
Company Announcements
Noxopharm Half-Year Loss Widens as Net Tangible Assets Turn Negative
4M ago
NOX
Noxopharm Issues 15 Million New Shares Under Financing Facility
PremiumCompany Announcements
Noxopharm Issues 15 Million New Shares Under Financing Facility
4M ago
NOX
Noxopharm Issues 15 Million New Shares Under Financing Facility
PremiumCompany Announcements
Noxopharm Issues 15 Million New Shares Under Financing Facility
4M ago
NOX
Noxopharm Secures $2.8m R&D Rebate to Advance Sofra Clinical Programs
PremiumCompany Announcements
Noxopharm Secures $2.8m R&D Rebate to Advance Sofra Clinical Programs
4M ago
NOX
Noxopharm Secures Flexible $5m At-the-Market Equity Facility with Acuity Capital
PremiumCompany Announcements
Noxopharm Secures Flexible $5m At-the-Market Equity Facility with Acuity Capital
4M ago
NOX
Noxopharm’s Sofra Platform Science Published in Top Immunology Journal
PremiumCompany AnnouncementsNoxopharm’s Sofra Platform Science Published in Top Immunology Journal
5M ago
NOX
Noxopharm Clears Key Safety Milestone as HERACLES Trial Concludes and Sofra Platform Gains Global Traction
Premium
Company Announcements
Noxopharm Clears Key Safety Milestone as HERACLES Trial Concludes and Sofra Platform Gains Global Traction
5M ago
NOX
Noxopharm Clears Safety Milestone as HERACLES Trial for SOF-SKN Concludes
Premium
Company Announcements
Noxopharm Clears Safety Milestone as HERACLES Trial for SOF-SKN Concludes
6M ago
NOX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >